|
|
| (3 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| | <div style="-webkit-user-select: none;"> |
| | {|class="infobox" style="position: fixed; top: 65%; right: 10px; margin: 0 0 0 0; border: 0; float: right; |
| | |- |
| | | {{#ev:youtube|https://https://www.youtube.com/watch?v=fKXHxcV6eLU|350}} |
| | |- |
| | |} |
| __NOTOC__ | | __NOTOC__ |
| {{Vasculitis}} | | {{Vasculitis}} |
| | | {{CMG}}; {{AE}} {{MUT}} |
| {{CMG}}; '''Associate Editor-In-Chief:''' {{MUT}} | |
|
| |
|
| ==Overview== | | ==Overview== |
| Line 8: |
Line 13: |
|
| |
|
| ==Historical Perspective== | | ==Historical Perspective== |
| *[Disease name] was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
| |
| *In [year], [gene] mutations were first identified in the pathogenesis of [disease name].
| |
| *In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].
| |
| | | |
| ==Classification== | | ==Classification== |
| *[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
| |
| :*[group1]
| |
| :*[group2]
| |
| :*[group3]
| |
| *Other variants of [disease name] include [disease subtype 1], [disease subtype 2], and [disease subtype 3].
| |
| | | |
| ==Pathophysiology== | | ==Pathophysiology== |
| *The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3].
| | |
| *The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway.
| |
| *On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
| |
| *On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
| |
|
| |
| ==Causes== | | ==Causes== |
| * [Disease name] may be caused by either [cause1], [cause2], or [cause3].
| |
| * [Disease name] is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
| |
| * There are no established causes for [disease name].
| |
|
| |
| ==Differentiating [disease name] from other Diseases==
| |
| *[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:
| |
| :*[Differential dx1]
| |
| :*[Differential dx2]
| |
| :*[Differential dx3]
| |
| | | |
| | ==Differentiating Vasculitis from other Diseases== |
| | |
| ==Epidemiology and Demographics== | | ==Epidemiology and Demographics== |
| * The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
| |
| * In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].
| |
| | | |
| ===Age=== | | ===Age=== |
| *Patients of all age groups may develop [disease name].
| |
|
| |
| *[Disease name] is more commonly observed among patients aged [age range] years old.
| |
| *[Disease name] is more commonly observed among [elderly patients/young patients/children].
| |
| | | |
| ===Gender=== | | ===Gender=== |
| *[Disease name] affects men and women equally.
| | |
|
| |
| *[Gender 1] are more commonly affected with [disease name] than [gender 2].
| |
| * The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.
| |
|
| |
| ===Race=== | | ===Race=== |
| *There is no racial predilection for [disease name].
| | |
|
| |
| *[Disease name] usually affects individuals of the [race 1] race.
| |
| *[Race 2] individuals are less likely to develop [disease name].
| |
| | | |
| ==Risk Factors== | | ==Risk Factors== |
| *Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
| | |
|
| |
| == Natural History, Complications and Prognosis== | | == Natural History, Complications and Prognosis== |
| *The majority of patients with [disease name] remain asymptomatic for [duration/years].
| | |
| *Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
| |
| *If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
| |
| *Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
| |
| *Prognosis is generally [excellent/good/poor], and the [1/5/10year mortality/survival rate] of patients with [disease name] is approximately [#%].
| |
| | | |
| == Diagnosis == | | == Diagnosis == |
| ===Diagnostic Criteria=== | | ===Diagnostic Criteria=== |
| *The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:
| | |
| :*[criterion 1]
| |
| :*[criterion 2]
| |
| :*[criterion 3]
| |
| :*[criterion 4]
| |
|
| |
| === Symptoms === | | === Symptoms === |
| *[Disease name] is usually asymptomatic.
| | |
| *Symptoms of [disease name] may include the following:
| |
| :*[symptom 1]
| |
| :*[symptom 2]
| |
| :*[symptom 3]
| |
| :*[symptom 4]
| |
| :*[symptom 5]
| |
| :*[symptom 6]
| |
| | | |
| === Physical Examination === | | === Physical Examination === |
| *Patients with [disease name] usually appear [general appearance].
| | |
| *Physical examination may be remarkable for:
| |
| :*[finding 1]
| |
| :*[finding 2]
| |
| :*[finding 3]
| |
| :*[finding 4]
| |
| :*[finding 5]
| |
| :*[finding 6]
| |
| | | |
| === Laboratory Findings === | | === Laboratory Findings === |
| *There are no specific laboratory findings associated with [disease name].
| |
|
| |
|
| *A [positive/negative] [test name] is diagnostic of [disease name].
| |
| *An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
| |
| *Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
| |
| | | |
| ===Imaging Findings=== | | ===Imaging Findings=== |
| *There are no [imaging study] findings associated with [disease name].
| | |
|
| |
| *[Imaging study 1] is the imaging modality of choice for [disease name].
| |
| *On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
| |
| *[Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].
| |
| | | |
| === Other Diagnostic Studies === | | === Other Diagnostic Studies === |
| *[Disease name] may also be diagnosed using [diagnostic study name].
| | |
| *Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].
| |
| | | |
| == Treatment == | | == Treatment == |
| === Medical Therapy === | | === Medical Therapy === |
| *There is no treatment for [disease name]; the mainstay of therapy is supportive care.
| | |
|
| |
| *The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
| |
| *[Medical therapy 1] acts by [mechanism of action 1].
| |
| *Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].
| |
| | | |
| === Surgery === | | === Surgery === |
| *Surgery is the mainstay of therapy for [disease name].
| | |
| *[Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
| |
| *[Surgical procedure] can only be performed for patients with [disease stage] [disease name].
| |
|
| |
| === Prevention === | | === Prevention === |
| *There are no primary preventive measures available for [disease name].
| |
|
| |
| *Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
| |
|
| |
| *Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].
| |
|
| |
|
| ==References== | | ==References== |
| {{Reflist|2}} | | {{Reflist|2}} |
| | |
| | [[Category:Rheumatology]] |
|
| |
|
| {{WH}} | | {{WH}} |
| {{WS}} | | {{WS}} |